PAUL BUSHDID joined Southern Research to lead its Developmental & Reproductive Toxicology program. Previously, Bushdid spent 13 years at GlaxoSmithKline, where he headed an Investigative Developmental Toxicology group, where his work focused on agents that can cause birth defects or halt pregnancies. Bushdid’s team was also involved in DART assessments of traditional Chinese medicines, study...
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
